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A model system was developed and successfully used to generate a range of Cheddar-
type enzyme-modified cheese (EMC) flavours from base dairy ingredients using
selected commercial enzymes and lactic acid bacteria. 
This process can be used at laboratory scale to screen enzymes and lactic acid bacteria
for their flavour generating capacity, or scaled up to produce EMC products.  The
process is easily modified to create a myriad of natural cheese-type flavours.
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Summary and Conclusions
Natural cheese flavour ingredients, in the form of enzyme modified
cheeses (EMCs), are widely used in the convenience food industry
and can provide high volume added opportunities for the cheese
industry.
Many EMCs are produced using commercial enzyme preparations
and previous studies have indicated that they contain side activities in
addition to their stated main activity (see DPRC Report No.10).
Therefore, it is critical that the exact enzyme complement of these
preparations are known before they can be used to produce EMC of
specific requirements on a consistent basis.
The scientific basis of rapid enzyme mediated flavour formation in the
production of EMCs is not fully understood.  Consequently this
knowledge gap is a major obstacle in the development of high value
cheese flavour ingredients. 
Hence, a major objective of this project was to deepen the scientific
understanding of flavour formation with a view to the production of
natural enzyme-mediated dairy flavour ingredients with commercial
potential.
The ultimate aim was to develop the technology to produce
customised high value dairy flavour ingredients in an optimised
process.
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Development of an EMC Model System
In this study the main component of the substrate used for EMC
production consisted of a high moisture, high pH, rennet cheese curd,
produced from full fat milk without starter culture.  This rennet curd
was blended with anhydrous butterfat, de-ionised water, salt and
emulsifying salts in a Stephan cooker until homogeneous and
subsequently heat-treated at 80…C for 20 min.  Rennet curd was
chosen as it is cheap to produce and any flavour subsequently
developed in the production processes could be directly attributed to
added enzymes rather than indigenous enzymes in the cheese curd.
Anhydrous butterfat was added to provide more substrate for lipolysis
as previous studies have shown that the level of lipolysis in EMCs is
linked to flavour intensity.
In the process, enzymes and/or lactic acid bacteria are added to the
substrate in a reaction vessel with constant agitation under controlled
temperatures for a fixed period, after which the product is batch heat-
treated to at least 80…C for 20 min.  This system can be used at
laboratory scale (1 - 2 kg) or production scale (1000 kg).  The choice
of processing conditions depends upon the enzymes or starter
cultures added, and the flavour required.
A temperature of 45…C and a processing time of 24 h period was
used.
Investigating the Flavour Potential of Combinations of
Commercial Enzymes in a Model System
The model system developed was used to investigate the potential of
a selected number of commercial enzyme preparations to produce
Main Conclusions and Achievements
* A model system was developed to evaluate the potential of
commercial enzymes and lactic acid bacteria to produce customised
Cheddar flavour EMC products in an optimised environment.
The importance of selected hydrolysis, compositional and production
parameters in the production of EMC were identified.
* The model EMC system can be used to produce a range of
differing cheese flavoured EMC products from base dairy ingredients
comparable to commercial products utilising combinations of
commercial enzymes and/or lactic acid bacteria.
* Manipulation of compositional, proteolytic and lipolytic
parameters, and the inclusion of glutamic acid can be used to develop
distinctly different products for specific applications.
Research and Results
Commercial Enzyme Study
A comprehensive study on the enzyme activities of a range of food
grade commercial enzymes was completed and reported in DPRC
Report No.10.  The study highlighted the necessity for more detailed
information on the specificity of the main enzyme component and for
information relating to side enzyme activities from suppliers.
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Table 1: Description and dose rates of commercial proteolytic enzymes used in the
production of preliminary EMC products in Step 1.
Proteinase Preparation Peptidase Preparation
(Conc. w/w)  + (Conc. w/w)
EMC 1 Glutaminase F* (0.026% w/w)            +   Debritase DBP20** (0.3% w/w)
EMC 2 Protease A Amano 6* (0.005% w/w)   +   Debritase DBP20** (0.3% w/w)
EMC 3 Bioprotease A Conc*** (0.50% w/w)   +   Debritase DBP20** (0.3% w/w)
EMC 4 Neutrase 0.5L**** (0.01%w/w)           +   Debritase DBP20** (0.3% w/w)
* Amano Enzyme Europe Ltd, Chipping Norton, Oxfordshire OX7 5SR, UK
** Rhodia-Foods UK, Stockport, Cheshire SK6 1PQ, UK
*** Quest International, Carrigaline, Co. Cork, Ireland
**** Novozymes A/S, Bagsvaerd, Denmark
Table 2: Primary and secondary proteolytic levels in EMC products 1 - 4 and the commercial
target EMC.
Product WSN (% TN) PTA-N (% TN) Total FAA (ug/g)
Av sd Av sd Av sd
EMC 1 58.90      0.13 12.20 0.30 10165 85 
EMC 2 53.10      0.19 11.30 0.12 10908 1067
EMC 3 54.80 5.08 7.30        0.00 9449 2723
EMC 4 55.40 0.40 6.80        0.19 7548 263
Commercial 52.07 1.90 21.39 1.40 23496 308
EMC 
WSN =   pH 4.6 water soluble nitrogen
PTA-N    =   5% Phosphotungstic acid soluble nitrogen
FAA =   Free amino acids
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good Cheddar-type EMC flavour in a two step process: Step 1
consisting of hydrolysis using only proteolytic enzymes, followed by
Step 2 which involves treatment with lipase preparations.  
The products produced were compared to a commercial EMC
product previously shown to have good Chedder-type flavours by a
trained descriptive sensory panel. All products were assessed for
compositional, proteolytic, lipolytic and sensory properties; trials
were carried out in triplicate.
Four EMC products (EMC 1 - 4) were produced using only proteolytic
enzymes, and in the second step one of these products was
subsequently used as the substrate to produce four EMC final
products (EMC 5 - 8) using lipase preparations.  These final products
were compared to the target commercial EMC product.
Step 1: Preliminary proteolysed EMC products (EMC 1 - 4)
Four commercial proteinase preparations were used which were
derived from Bacillus subtilis, Aspergillus oryzae or Aspergillus niger.
These enzymes were selected on the basis of their differing activity
towards sodium caseinate.  One of the preparations, Glutaminase F
contained glutaminase activity, which produces free glutamic acid, a
natural flavour enhancer, known to be useful in EMC production.
A peptidase preparation derived from  Aspergillus oryzae and
Lactococcus lactis was added to each EMC product (1 - 4) to aid
flavour development and control bitterness. 
A description of each enzyme preparation and the dose rates used are
given in Table 1.
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most likely due to a number of factors including higher levels of
protein in the commercial product, the use of higher levels of
peptidase in its manufacture, the use of pre-hydrolysed substrate
(mature cheese) or from high levels of free glutamic acid which could
have been added exogenously.
Statistical analysis of the sensory results by ranked preference found
no significant difference between EMCs 1 - 4; however as EMC 4 had
the highest preferred score, it was thus used as a source of substrate
for the production of the final EMC products in Step 2 of the process.
Step 2: Final lipolysed EMC products (EMC 5 - 8)
Lipase preparations were selected based on their specificity and were
derived from Penicillium roqueforti, Mucor miehei, Candida rugosa
or pancreatic tissue.  A description of each enzyme preparation and
the dose rates used are given in Table 3.
The gross compositions of the resulting products were similar.
Levels of proteolysis only increased in EMC 6, which was probably
due to the presence of a trypsin-like side proteinase activity,
previously found in the lipase preparation used in its production
(Table 4).  Fatty acid profiles of EMCs 5 - 8 and the commercial
product are shown in Fig. 2.  The amount of free fatty acids in these
products appear quite similar despite the fact that lipases of differing
specificity were used in their production.
This appears to indicate that lipase specificity is not an issue in
systems where very high levels of lipolysis are attained.
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Only slight differences were found in terms of composition between
EMCs 1 - 4, each having similar levels of primary and secondary
proteolysis as measured by WSN (%TN) and PTA - N (%TN)
respectively (Table 2).  However, differences in free amino acid
contents (Table 2 and Fig. 1) were apparent between these products
and can be directly attributed to differences in the specificity of the
proteinases used in their preparation.  EMC 1 had the highest level of
free glutamic acid, confirming the presence of glutaminase activity in
the enzyme preparation used in its production.  High levels of certain
free amino acids (leucine, lysine, valine, phenylalanine and histidine)
in EMCs 1 - 4 were due to the action of the peptidase preparation,
which had been previously shown to have high levels of general
aminopeptidase activity.
Levels of primary proteolysis in EMCs 1 - 4 were similar to the
commercial product, but levels of secondary proteolysis were
considerably lower.  This difference in secondary proteolysis was
8
Fig. 1: Free Amino Acid Profiles of EMCs 1 - 4 and the commercial product.
Statistical analysis of the sensory results by ranked preference found
no significant difference between preference of these products and the
commercial Cheddar-type EMC.
This result appears to indicate that the overall sensory perception of
these products was quite similar indicating that they are comparable
to the commercial product.
Detailed descriptive sensory analysis found that EMCs 5, 7 and 8
were the most similar and this could be attributed to the fact that their
compositional, proteolytic and lipolytic parameters were also the
most similar.  EMC 6 was distinguished from all other products and
was most likely due to its different levels of proteolysis and lipolysis.
The commercial product was distinguished from EMCs 5, 7 and 8
which appeared to be due to differences in composition and
secondary proteolysis and levels of free glutamic acid as their lipolytic
profiles were quite similar.
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Table 3: Description and dose rates of commercial lipolytic enzymes used in the production
of final EMC products in Step 2.
EMC 5 Lipomod 338* (0.50% w/w)
EMC 6 Lipomod 299* (0.90% w/w)
EMC 7 Palatase 20,000L** (5.50% w/w)
EMC 8 Lipase AY30 Amano***(0.50% w/w)
* Biocatalysts Ltd, Main Avenue, Pontypridd CF37 5UT, UK
** Novozymes A/S, Bagsvaerd, Denmark
*** Amano Enzyme Europe Ltd, Chipping Norton, Oxfordshire OX7 5SR, UK
Table 4: Proteolytic and lipolytic indices of EMCs.
Product WSN PTA-N Total FAA   Acid Degree     Total FFA
(% TN) (% TN) (ug/g) Value (ug/g)
Av sd Av        sd        Av       sd Av         sd           Av        sd
EMC 5 50.40    1.44 9.90     0.60    6968    383      20.7      0.7       63290    4416
EMC 6 78.30    3.60     36.10   10.76    9756    578      15.3      0.4       26993    4979
EMC 7     51.20    1.47     10.33     0.15    7292     218      22.6       2.1       66445     4002
EMC 8     50.33    0.47      9.33     0.31   7816     359      22.8     0.5       65843     7171
Commercial 
EMC 52.07    1.90    21.39    1.40    23496    308      20.4     0.1   57978    5749
WSN =   pH 4.6 water soluble nitrogen
PTA-N   =   5% Phosphotungstic acid soluble nitrogen
FAA =   Free amino acids
FFA =   Free fatty acids (C4:0 - C18:3)
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Fig. 2: Free Fatty Acid Profiles of EMCs 5 - 8 and the commercial product.
enzyme preparations Savourase RST100 (Rhodia-Foods UK) and
Lipomod 338 (Biocatalysts, UK) for 6 h at 45…C and at 0.42% w/v
and 0.11% w/v, respectively.  After heat treatment at 80…C for 30 min,
one batch was inoculated with viable (1010 cfu/ml) cells of
Lb. helveticus, while a second was inoculated with an equivalent
amount of heat-shocked cells (optimum 69…C for 25 s) and incubated
for a further 24 h at 37…C.  The reaction was terminated by heat
treatment at 80…C for 30 min.  This experiment was carried out in
triplicate and samples were taken for analysis at 0, 8, 16 and 24 h.
All samples had essentially similar compositions, except for a more
pronounced reduction in pH in the product produced using viable
cells.  In general, proteolysis increased in both products, with a
slightly higher level in the heat-shocked cells, presumably due to early
release of intracellular enzymes.  Levels of volatile short chain free
fatty acids (C4:0 and C6:0) remained constant in the viable cell
product, but increased slightly in the heat-shocked product.  Some
differences in the volatile flavour profiles as measured by GC/MS
were also noted between both products.  
Sensory evaluation on the basis of ranked preference showed an
increase in acceptability for heat-shocked product over the viable cell
product.  A decrease in sensory acceptability appeared to correspond
with decreasing in pH, which in turn was linked to an increase acetic
acid, which became more pronounced in the viable cell product.
The results show that it is possible to produce acceptable intense
Cheddar-type EMC flavours using starter cultures, specifically
Lb. helveticus (DPC 4571) in combination with commercial enzymes
utilising the model system.  This mechanism could be further
exploited to produce a range of intensely cheesey-flavoured EMC.
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This work has shown that a model EMC system can be used to
produce different Cheddar-type EMCs comparable to commercial
products from base dairy substrates.  Differences in aroma and flavour
identified between these products appears to be related to differences
in defined compositional, proteolytic, lipolytic parameters and levels
of free glutamic acid.
Assessing the Potential to Develop EMC Utilising
Commercial Enzymes and Lactic Acid Bacteria in a Model
System
Commercial EMCs have some limitations which preclude their use in
some processed consumer foods.
These limitations generally relate to inconsistent flavour development
and an inability to mimic natural cheese flavours.  To overcome these
problems it was decided to investigate the potential of utilising lactic
acid starter bacteria cultures used in natural cheese production for
EMC production, since Lactobacilli are a good source of important
flavour producing enzymes.
In this study a strain of Lactobacillus helveticus (DPC 4571) was
chosen as previous work has shown that it is autolytic and accelerated
natural Cheddar cheese ripening.  The objective of this study was to
investigate the potential of viable and heat-shocked cells (heat
shocking causes lysis and inactivates the cells lactose fermenting
ability without affecting residual enzyme activity) of Lactobacillus
helveticus DPC 4571 in the production of Cheddar-flavoured EMC.
Like the previous study a two step approach was taken.  Using the
model system the substrate was hydrolysed by two commercial
12
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